公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2020 | Use of glecaprevir/pibrentasvir in patients with chronic hepatitis c virus infection and severe renal impairment | Yap D.Y.H.; Liu K.S.H.; Hsu Y.-C.; Wong G.L.H.; Tsai M.-C.; CHIEN-HUNG CHEN ; Hsu C.-S.; Hui Y.T.; Li M.K.K.; CHEN-HUA LIU ; Kan Y.-M.; Yu M.-L.; Yuen M.-F. | Clinical and Molecular Hepatology | 7 | 8 | |
2010 | Use of statins and gallstone risk [1] | Hsu C.-S.; JIA-HORNG KAO | JAMA - Journal of the American Medical Association | 4 | 3 | |
2014 | Vinyl acetate living radical polymerization mediated by cobalt porphyrins: Kinetic-mechanistic studies | Hsu C.-S.; Yang T.-Y.; CHI-HOW PENG | Polymer Chemistry | 39 | 36 | |
2013 | Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir | Wang C.-C.; Tseng K.-C.; Peng C.-Y.; Hsieh T.-Y.; Lin C.-L.; TUNG-HUNG SU ; TAI-CHUNG TSENG ; Hsu C.-S.; Lin H.H.; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 24 | 26 |